Priyanka Pophali is an Oncology physician affiliated with University of Wisconsin–Madison. OpenAlex indexes 99 publications with 778 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
4 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
39.9%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor39.9%Acyclovir100%Part D≥47 patientsMetabolism & gastrointestinal
22.4%H2 blocker8.8%Famotidine100%Part D≥16 patientsCorticosteroid5.8%Prednisone100%Part D≥18 patients+ 2 more classes in this area
Anti-infectives
21.8%Short-acting sulfonamides17.4%Sulfamethoxazole-Trimethoprim100%Part D≥21 patientsAzole Antifungal2.4%Fluconazole100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: A CIBMTR Analysis
Transplantation and Cellular Therapy
2025 - Self-efficacy for cancer self-management in the context of COVID-19: a cross-sectional survey study
Supportive Care in Cancer
2025
Similar KOLs
Other experts from the same institution or the same specialty.
William Busse, MD
University of Wisconsin–Madison
David Andes, MD
University of Wisconsin–Madison
Neil Binkley, MD
University of Wisconsin–Madison
Barbara Klein, MD, MPH
University of Wisconsin–Madison
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”